Lange, P.S.; Frommeyer, G.; Kleemann, T.; Brachmann, J.; Lugenbiel, P.; Reif, S.; Hochadel, M.; Senges, J.; Eckardt, L.
Pacemaker Versus Defibrillator Therapy in Patients Eligible for Cardiac Resynchronisation Therapy: Evidence from the German Device Registry. J. Clin. Med. 2025, 14, 1137.
https://doi.org/10.3390/jcm14041137
AMA Style
Lange PS, Frommeyer G, Kleemann T, Brachmann J, Lugenbiel P, Reif S, Hochadel M, Senges J, Eckardt L.
Pacemaker Versus Defibrillator Therapy in Patients Eligible for Cardiac Resynchronisation Therapy: Evidence from the German Device Registry. Journal of Clinical Medicine. 2025; 14(4):1137.
https://doi.org/10.3390/jcm14041137
Chicago/Turabian Style
Lange, Philipp S., Gerrit Frommeyer, Thomas Kleemann, Johannes Brachmann, Patrick Lugenbiel, Sebastian Reif, Matthias Hochadel, Jochen Senges, and Lars Eckardt.
2025. "Pacemaker Versus Defibrillator Therapy in Patients Eligible for Cardiac Resynchronisation Therapy: Evidence from the German Device Registry" Journal of Clinical Medicine 14, no. 4: 1137.
https://doi.org/10.3390/jcm14041137
APA Style
Lange, P. S., Frommeyer, G., Kleemann, T., Brachmann, J., Lugenbiel, P., Reif, S., Hochadel, M., Senges, J., & Eckardt, L.
(2025). Pacemaker Versus Defibrillator Therapy in Patients Eligible for Cardiac Resynchronisation Therapy: Evidence from the German Device Registry. Journal of Clinical Medicine, 14(4), 1137.
https://doi.org/10.3390/jcm14041137
